Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POLO study of pregabalin or lacosamide added to oxycodone on breathing in healthy volunteers
NL-OMON53730Phase 4Completed
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of oxycodone, pregabalin and lacosamide (3 arms), sponsored by Leiden University Medical Center. Primary endpoint: Extrapolated ventilation at end-tidal PCO2 of 55 mmHg (VE55). Started Oct 2022; status: completed.
02
Drugs
oxycodonepregabalinlacosamide
Beyond the preview
Go deeper on NL-OMON53730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53730.